It was April 23 when an AstraZeneca study highlighted the potential risks for younger people in case of administration. In in particular, with the study on thrombosis it emerged already over a month and a half ago that the undesirable effects of the vaccine developed by the Anglo-Swedish pharmaceutical company could represent, for the younger age groups, a greater risk than the general benefits.
The Ema study that warned about the risks of AstraZeneca vaccines to under 30s
“In the presence of alternatives, it may therefore be preferable – for a strategy of maximum caution – to use another type of dose”, we read in the report that today is quoted at the opening by La Verità in an article by Daniele Capezzone. “Who had to be protected, because potentially vulnerable, has already had his injection. So why expose the little ones to the risks (albeit limited, but still the risks) of a vaccination?” Capezzone writes.
Sileri: “If I had a friend under 30 I would tell her not to take AstraZeneca”
The article cites the ideas of Giuseppe Remuzzi, Luca Ricolfi and Mario Menichella on vaccines and younger age groups. On the other hand, only a few days ago even the Undersecretary of Health Pierpaolo Sileri declared: “The doubts arise even more from the fact that today the circulation and the weekly incidence of the virus have dropped drastically. It is clear that if a vaccine has given the suspicion of some complications, especially in younger people, the risk-benefit range for these subjects is reduced. And therefore it is likely that for non-mRna vaccines there may be a review of the indications on age, using greater caution today that the circulation of the virus is much lower. In my opinion under 30 it should not be used, especially for women under 50 I would not recommend it, but it is Ema and Aifa who must evaluate this possible restriction. I booked at the pharmacy and I’ll do the J&J, but I’m over 40 and I’m not a woman so I can be pretty sure, but if I had a 30 year old friend I’d recommend an mRna vaccine “